Episode
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
- Podcast
- Business Of Biotech
- Published
- Jul 27, 2026
- Duration seconds
- 3286
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/using-genetics-to-discover-new-treatments-with-regeneron-genetics-center-s-aris-baras-m-d/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-of-biotech-123501/using-genetics-to-discover-new-treatments-with-regeneron-genetics-center-s-aris-baras-m-d.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Genetics Center (RGC) and Co-Head of Regeneron Genetic Medicines, talks about using large-scale human genetics to find better drug targets based on "superhuman" variants. Aris explains how multi-omics, linked health records, and AI are helping developers move faster in the clinic and reduce the odds of failure, while also pushing biotech toward ea...